* If you want to update the article please login/register
Prescription opioid drugs are a leading cause of opioid-related suicide in patients with cirrhosis of the liver, which affects 4 million people in the United States, and are especially risky in patients with cirrhosis of the liver. Despite these risks, our pilot study showed that nearly half of all patients with cirrhosis are prescribed opioid medications each year, and that these prescriptions are often inconsistent with opioid prescribing safety requirements. Moreover, existing opioid abuse and pain management programs for general populations do not address many of the particular problems faced by patients with cirrhosis. Patients at UPMC will be recruited for participation in the Liver Education About Pain intervention program, according to the study team. LEAP is a repeating group and individual sessions of a modular 12-week pain self-management program. The LEAP scheme is intended to make pain better, assist patients in meeting their personal goals, and assist the care patients' medical team.
Source link: https://clinicaltrials.gov/ct2/show/NCT05128578
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions